<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744936</url>
  </required_header>
  <id_info>
    <org_study_id>18-007275</org_study_id>
    <nct_id>NCT03744936</nct_id>
  </id_info>
  <brief_title>Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)</brief_title>
  <acronym>(DA4AFib)</acronym>
  <official_title>Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assist patients and clinicians to reach SDM about treatment options for patients with
      nonvalvular chronic Atrial Fibrillation screening the investigators aim to develop an
      evidence-based decision aid for use before the clinical encounters. Our goal is to promote
      evidence-based patient-centered care. Ideally, this care should reflect the research evidence
      about anticoagulation treatment. It should also reflect the values and preferences of the
      informed patient.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 4, 2018</start_date>
  <completion_date type="Anticipated">October 4, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decisional Conflict</measure>
    <time_frame>Immediatly following clinical visit</time_frame>
    <description>Decisional conflict will be measured using the decisional conflict scale</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>DA4Afib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Developing a tool to use during the encounter</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DA4Afib Prototyping</intervention_name>
    <description>We will develop a prototype from patients with atrial fibrillation</description>
    <arm_group_label>DA4Afib</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        1. Must be 18 or older

          2. Must have an appointment for Atrial Fibrillation

          3. Must not have dementia

          4. Must not have severe hearing or vision impairment Patients will be given a written
             consent Guests that accompany patients will be given an oral consent KER unit PAG
             members will be given an oral consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor M Montori</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela L Sivly, Bachelors</last_name>
      <phone>507-266-1734</phone>
      <email>sivly.angela@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Emma M Behnken, Bachelors</last_name>
      <phone>507-293-0177</phone>
      <email>behnken.emma@mayo.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 13, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>November 22, 2019</last_update_submitted>
  <last_update_submitted_qc>November 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Victor Montori</investigator_full_name>
    <investigator_title>MD, Prinicpal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

